Indomethacin-induced reduction in CRTH2 in eosinophilic pustular folliculitis (Ofuji's disease): a proposed mechanism of action. 2010

Takahiro Satoh, and Chieko Shimura, and Chiyako Miyagishi, and Hiroo Yokozeki
Department of Dermatology, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. tasa-1688.derm@tmd.ac.jp

Eosinophilic pustular folliculitis is an inflammatory skin disease characterized by pruritic follicular papulopustules. It is usually resistant to topical and/or systemic corticosteroids, but it responds well to systemic indomethacin. We report here two patients with classical-type disease who were treated with systemic indomethacin. As indomethacin is an inhibitor of cyclo-oxygenases and a potent agonist of the prostaglandin D2 (PGD2) receptor, CRTH2 (chemoattractant receptor homologous molecule expressed on Th2 cells), we investigated the effects of indomethacin on CRTH2 expression by leukocytes. CRTH2 was expressed on blood eosinophils and lymphocytes. In vitro treatment with indomethacin suppressed the expression of CRTH2 on these cells. In addition, systemic treatment with indomethacin reduced eosinophil CRTH2 expression in another patient in association with improvement of skin lesions and blood eosinophilia. A number of inflammatory cells expressed haematopoietic PGD synthase, an essential enzyme for generating PGD2 in skin lesions of eosinophilic pustular folliculitis. A PGD2-CRTH2 interaction may be involved in the pathogenesis. Moreover, indomethacin may exert its therapeutic effect via reducing CRTH2 expression, as well as by inhibiting PGD2 synthesis.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D011982 Receptors, Prostaglandin Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 (DP receptors), prostaglandin E2 (EP1, EP2, and EP3 receptors), prostaglandin F2-alpha (FP receptors), and prostacyclin (IP receptors). Prostaglandin Receptors,Prostaglandin Receptor,Receptor, Prostaglandin,Receptors, Prostaglandins,Prostaglandins Receptors
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D004802 Eosinophilia Abnormal increase of EOSINOPHILS in the blood, tissues or organs. Eosinophilia, Tropical,Hypereosinophilia,Tropical Eosinophilia,Hypereosinophilias,Tropical Eosinophilias
D004804 Eosinophils Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin. Eosinophil
D005260 Female Females

Related Publications

Takahiro Satoh, and Chieko Shimura, and Chiyako Miyagishi, and Hiroo Yokozeki
January 1993, Dermatology (Basel, Switzerland),
Takahiro Satoh, and Chieko Shimura, and Chiyako Miyagishi, and Hiroo Yokozeki
August 1997, Journal of the American Academy of Dermatology,
Takahiro Satoh, and Chieko Shimura, and Chiyako Miyagishi, and Hiroo Yokozeki
January 1988, Annales de dermatologie et de venereologie,
Takahiro Satoh, and Chieko Shimura, and Chiyako Miyagishi, and Hiroo Yokozeki
January 1992, Annales de dermatologie et de venereologie,
Takahiro Satoh, and Chieko Shimura, and Chiyako Miyagishi, and Hiroo Yokozeki
March 2001, Clinical and experimental dermatology,
Takahiro Satoh, and Chieko Shimura, and Chiyako Miyagishi, and Hiroo Yokozeki
August 1993, Archives of dermatology,
Takahiro Satoh, and Chieko Shimura, and Chiyako Miyagishi, and Hiroo Yokozeki
November 1998, The Journal of dermatology,
Takahiro Satoh, and Chieko Shimura, and Chiyako Miyagishi, and Hiroo Yokozeki
January 1989, Dermatologica,
Takahiro Satoh, and Chieko Shimura, and Chiyako Miyagishi, and Hiroo Yokozeki
January 2012, International journal of dermatology,
Takahiro Satoh, and Chieko Shimura, and Chiyako Miyagishi, and Hiroo Yokozeki
November 2006, Journal of the European Academy of Dermatology and Venereology : JEADV,
Copied contents to your clipboard!